Intercontinental Pharma Private Limited - Company Profile

It is a home appliances private limited company based in New Delhi, Delhi, India, established in 2013.

2013 New Delhi, Delhi, India Struck Off

Last Updated: July 25, 2025

About Intercontinental Pharma Private Limited

Intercontinental Pharma Private Limited, a struck off private limited company, was established on 19 March 2013 in New Delhi, Delhi, India. Engaging in wholesale within the home appliances sector, it holds CIN: U51397DL2013PTC249525. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.

Its leadership includes Mohammad Khaja Mohiuddin (Additional Director), Nizamuddin Shaik (Additional Director). Past directors included Chander Mohan Chandna, Ruchi Chandna, Janibhasha Shaik. It is based at 101-A, Kundan Kutir Hari Nagar, Ashram, New Delhi, Delhi, 110014.

Company Details

CIN/LLPIN
U51397DL2013PTC249525
Registration Number
249525
Incorporation Date
19 March 2013
Authorized Capital
₹0.50 M
Paid-Up Capital
₹0.10 M
ROC Code
Roc Delhi
Listing Status
Unlisted
Company Status
Struck Off

Key Metrics

Authorised Capital ₹ 0.50 M as on 25-07-2025
Paid Up Capital ₹ 0.10 M as on 25-07-2025
Company Age 13 Year, 1 Month

Comprehensive Company Insights

Explore comprehensive insights into Intercontinental Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Intercontinental Pharma Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Mohammad Khaja Mohiuddin	Additional Director	16 Dec 2013	Current
Nizamuddin Shaik	Additional Director	16 Dec 2013	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	16 Dec 2013	Past
Pramod Abcsdd	Director	16 Dec 2013	Past
Pramod Abcsdd	Additional Director	20 Feb 2017	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Intercontinental Pharma.

Enhance accessibility to Intercontinental Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

*******

Revenue from Operations

*******

Total Assets

*******

Profit or Loss

*******

Net Worth

*******

EBITDA

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Intercontinental Pharma?

Unlock access to Intercontinental Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Intercontinental Pharma?

Unlock and access historical data on people associated with Intercontinental Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Intercontinental Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Intercontinental Pharma's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Intercontinental Pharma

Recent Activity within the Organization

Director Appointment

Progress on Mohammad Khaja Mohiuddin was appointed as a Additional Director was appointed as a Additional Director on 16 Dec 2013 & has been associated with this company since 12 years 4 months . was documented.
16 Dec 2013
Director Appointment

The activity Nizamuddin Shaik was appointed as a Additional Director was appointed as a Additional Director on 16 Dec 2013 & has been associated with this company since 12 years 4 months . was completed.
16 Dec 2013
Company Incorporation

The activity Intercontinental Pharma Private Limited was registered on 19 Mar 2013 with Roc Delhi & aged 13 years 1 month as per MCA records. was completed.
19 Mar 2013

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions

What is the CIN of Intercontinental Pharma Private Limited?

The CIN of Intercontinental Pharma Private Limited is U51397DL2013PTC249525.

Where is Intercontinental Pharma Private Limited headquartered?

Intercontinental Pharma Private Limited is headquartered at 101-A, Kundan Kutir Hari Nagar, Ashram, New Delhi, Delhi, 110014.

When was Intercontinental Pharma Private Limited incorporated?

Intercontinental Pharma Private Limited was incorporated on 19 March 2013.

Who are the current directors of Intercontinental Pharma Private Limited?

The current directors of Intercontinental Pharma Private Limited are

What is the primary industry of Intercontinental Pharma Private Limited?

The primary industry of Intercontinental Pharma Private Limited is Home Appliances.

Is Intercontinental Pharma Private Limited a listed company?

Intercontinental Pharma Private Limited is unlisted.

What is the capital structure of Intercontinental Pharma Private Limited?

The authorized capital of Intercontinental Pharma Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available